ArticleTrials2026
An individualised Lifestyle Intervention with Physical Activity and Diet in individuals with overweight and obesity (LI-PAD)-study protocol of a 6-month randomised controlled study {1a}.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06379802 (Lifestyle Intervention With Physical Activity and Diet for Precision Health in Individuals With Overweight), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Lifestyle Intervention With Physical Activity and Diet for Precision Health in Individuals With Overweight: a 6-month Pilot Randomized Controlled Trial (LI-PAD)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOverweight and obesity increase the risk of cardiometabolic disease, and sustainable lifestyle change remains difficult to achieve. The primary objective of this randomised controlled trial will be to identify whether a 6-month individualised intervention in physical activity and diet, offering flexible support strategies, is effective and feasible and leads to larger improvements in weight loss, other cardiometabolic disease risk factors, and health-related quality of life compared with standard written lifestyle advice.
methodsEligible participants will be 45-65 years old men and women residing in the Gothenburg area, with a body mass index of ≥28 and <35. We intend to recruit 120 females and males, who are randomly allocated in a 1:1 ratio to either the intervention or control group. The intervention group will undergo a 6-month intervention of individually tailored support and guidance on lifestyle behaviours encompassing physical activity and dietary modifications. The control group will receive standard lifestyle advice based on general physical activity and dietary recommendations, respectively. The primary outcome measure will be weight loss from baseline to the 6-month follow-up. The study will be conducted at the Centre for Lifestyle Intervention, Sahlgrenska University Hospital, Gothenburg, Sweden. Data analysis will employ multilevel mixed modelling for repeated measures, alongside linear and logistic analyses, adhering to an intention-to-treat approach. DISCUSSION: By addressing critical health metrics, such as weight, blood pressure, and physical activity, using individualised advice based on objective data, this intervention will move beyond a one-size-fits-all strategy when tackling complex behaviour change challenges in overweight and obesity management and reducing cardiometabolic disease risk. Introducing health promoters in a clinical setting will be a novel approach.
trial registrationThe study is prospectively registered on researchweb.org on 2 January 2024 (project number 281907) and subsequently at ClinicalTrials.gov, NCT06379802 on 9 February 2024 (approval number/ID: 2023-00546-01).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.